Member of the Managing Board
and Senior Executive Officer
Senior Managing Director
Since entering the 21st century, many companies have become more proactive in their CSR activities, with corporate social responsibility extending to address climate change and other environmental problems, as well as such social issues as harassment, discrimination and other human rights problems. In 2015, the United Nations adopted the Sustainable Development Goals (SDGs), which promote initiatives to resolve issues globally. In addition to pursuing sustainable growth in operating performance, including sales and profits, corporate management is being called upon to also prioritize the environment, society and governance (ESG).
Taking such social changes into account, Sysmex has identified priority issues (materiality) from an ESG perspective, set non-financial targets in its Group mid-term management plan, and is pursuing initiatives to resolve these issues. Sysmex’s business itself contributes to the resolution of social issues. Through our products and services, we address medical issues. In addition to the responsible provision of products and services, we are environmentally considerate throughout the product life cycle, and work proactively to reduce the environmental burden at our business and production facilities.
Through a host of corporate activities, we promote bilateral communication inside and outside the Group to earn the trust of our stakeholders and engage in initiatives to further enhance corporate value.
Sysmex believes its corporate responsibility is to instill trust and confidence among stakeholders by putting into practice the “Sysmex Way”, the corporate philosophy for the Sysmex Group.
The “Sysmex Way” indicates the way the most basic corporate activities ought to be conducted, consisting of three elements necessary for continued growth through contributing to society: Mission, Value, and Mind. Our mission expresses the expansion of our business from activities centered on the field of in vitro diagnostics—a focus since our establishment—to the broader healthcare domain with its even closer connection to human health. In this manner, our mission asserts our aim of contributing toward the realization of a society filled with abundance, health, and joy.
The Sysmex Way’s Core Behaviors clarify the provision of specific value to customers, employees, business partners, shareholders, society, and all other stakeholders. For example, to instill trust and confidence in all members of society we carry out our business in strict compliance with laws and regulations, as well as in adherence to high ethical standards. We also consider it important to play an active role in resolving environmental issues and other problems that impact our society today.
Sysmex has established the CSR Promotion Department as a specialized department for planning, drawing up proposals for, and promoting CSR activities, and disseminating CSR-related information both inside and outside the Company. The department’s activities are conducted under the control and management of senior managing director and member of the Managing Board, Yukio Nakajima.
The Group mid-term management plan (fiscal years ending March 31, 2020 to 2022) sets ESG-related targets tied to materiality, clarifying the position of CSR activities within the overall management scheme. Individual departments will roll out execution plans and activities to achieve these ESG-related targets and report their progress at management meetings. Targets are then reviewed and new measures considered, in a PDCA cycle.